Invention Grant
- Patent Title: Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
-
Application No.: US17962781Application Date: 2022-10-10
-
Publication No.: US12054474B2Publication Date: 2024-08-06
- Inventor: Colm Carroll , Anne Goldby , Martin Teall
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP
- Agency: BARNES & THORNBURG LLP
- Agent Scott D. Rothenberger
- Priority: GB 09587 2012.05.30
- The original application number of the division: US15262436 2016.09.12
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K31/4545 ; A61K45/06 ; C07D211/96 ; C07D401/12 ; C07D401/14
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof.
in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
Public/Granted literature
- US20230073334A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES Public/Granted day:2023-03-09
Information query
IPC分类:
